Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 47

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

553	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	03/03/2014 2:20:52 PM
552	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	03/03/2014 1:05:58 PM
551	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	03/03/2014 11:48:28 AM
550	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/03/2014 10:58:21 AM
549	Have been in this since .12. Truly believe in	HennypennyAZ	03/03/2014 9:57:08 AM
548	$NVLX Nuvilex Begins Making Moves at its	stocklegend	03/03/2014 9:55:48 AM
547	NVLX news:	stocklegend	03/03/2014 9:22:04 AM
546	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	03/03/2014 8:46:44 AM
545	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/28/2014 2:31:42 PM
544	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/28/2014 2:01:26 PM
543	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/28/2014 12:47:46 PM
542	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/28/2014 12:10:13 PM
541	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/28/2014 11:20:38 AM
540	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/28/2014 10:30:22 AM
539	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/28/2014 10:13:27 AM
538	NVLX Stock Charts Last: -0.0423 Friday, February	chartguy89	02/28/2014 10:09:44 AM
537	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/28/2014 8:58:29 AM
536	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/27/2014 3:25:05 PM
535	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/27/2014 3:22:32 PM
534	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	02/27/2014 2:08:46 PM
533	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/27/2014 1:26:09 PM
532	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	02/27/2014 12:25:56 PM
531	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/27/2014 12:00:27 PM
530	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/27/2014 11:27:58 AM
529	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/27/2014 10:50:53 AM
528	$NVLX - Nuvilex Restructures its Operations to	stocklegend	02/27/2014 10:18:56 AM
527	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/27/2014 9:54:20 AM
526	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/27/2014 9:22:29 AM
525	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/27/2014 8:55:15 AM
524	Looking soo good right now!	anarmyofme	02/26/2014 8:50:54 PM
523	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/26/2014 3:08:56 PM
522	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/26/2014 1:51:29 PM
521	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/26/2014 12:28:54 PM
520	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/26/2014 11:49:57 AM
519	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/26/2014 11:21:01 AM
518	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/26/2014 10:40:53 AM
517	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/26/2014 10:11:47 AM
516	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/26/2014 9:47:26 AM
515	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/26/2014 9:30:16 AM
514	NVLX news:	stocklegend	02/26/2014 8:55:41 AM
513	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	02/25/2014 3:47:00 PM
512	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/25/2014 3:32:11 PM
511	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	02/25/2014 2:52:29 PM
510	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/25/2014 2:05:17 PM
509	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/25/2014 1:15:48 PM
508	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/25/2014 12:06:09 PM
507	$NVLX - Nuvilex Restructures its Operations to	stocklegend	02/25/2014 10:57:27 AM
506	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/25/2014 10:02:39 AM
505	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/25/2014 9:31:05 AM
504	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/25/2014 9:03:48 AM

Newer

Older

Recent Articles

• Notting Hill Genesis Plans Major Improvements After Review
• Tectonic Gold Strengthens Portfolio with Strategic Moves
• JPMorgan's Insight: Upgrading Mexico While Downgrading Brazil's Prospects
• Exploring Market Reactions Amid Geopolitical Developments
• Impact of Tariffs on General Motors and the Automotive Market
• Vanguard's 2025 Market Insights: Stocks and Economic Dynamics
• Skyquest's Innovative Partnership for Water Management in Ethiopia
• European Metals Holdings Faces Shareholder Discontent with Pay Report
• Ironveld PLC Experiences Shift in Shareholder Dynamics
• Understanding the Current Decline of the Russian Rouble
• Just Eat Takeaway Announces Delisting Plans for Growth
• Unlocking Blockchain Potential: Aventus Launches Game-Changing Factory
• Discover the Scenic Beauty of China’s Cui-Gui Country Road
• MARA Holdings Calls for Increased US Bitcoin Mining Support
• Exploring the Phenomenon: The Saylor Effect on ETFs and Stocks
• BingEx Limited Reports Impressive Q3 2024 Revenue Growth
• Unexpected Decline in French Consumer Confidence in November
• German Consumer Sentiment Falls Amid Job Cut Concerns
• Bank of America Predicts Metal Prices to Fluctuate by 2025
• Potential Tariffs Could Shift Oil Trade Towards Asia
• Goldman Sachs Highlights Tariff Risks for US Consumers and Industry
• Sareum Holdings plc Announces Details for Upcoming AGM
• Emirates Airline Faces Growth Challenges Due to Boeing Delays
• Pets at Home Faces Challenges Amid Market Headwinds
• Understanding Recent Trends in Home Prices: A Comprehensive Overview
• S&P 500's Journey Towards New Heights Amid Trade Concerns
• Rivian's Major Loan Approval Amid EV Tax Changes
• Strategizing Your Trades as E-Mini Dow Jones Reaches New Heights
• Tech Sector Outlook: Can XLK Hit New Heights This December?
• Thanksgiving Stock Highlights: Three Winning Companies for 2024
• Panda Partners Event Highlights Nature and Community Initiatives
• Rock Tech Lithium's Guben Converter Site Milestone Achievements
• Xtrackers ETFs Embrace New ESG Standards for Investors
• Xtrackers Enhances ESG Standards for Its ETFs: A New Era
• Gradual ECB Policy Adjustment: Insights from Isabel Schnabel
• Anchor Hanover Achieves Impressive Growth in Financial Results
• Playtech Sets Date for General Meeting on Executive Pay Policy
• Market Trends: Examining Inflation, Tariffs, and Tech Challenges
• SpaceX Secures FCC License for Starlink Direct-to-Cell Services
• CBB International Sukuk Implements Market Stability Strategies
• EasyJet's Profits Surge as Demand for Travel Soars
• European Market Downturn: Tariffs Spark Concerns for Investors
• Upcoming Earnings Reports to Watch This November
• Standard Chartered Refocuses Strategy with African Divestments
• Impact of Tariff Policies on European Markets and Economies
• Dell Technologies Faces Challenges Ahead of Q4 as Earnings Rise
• Indonesian Market Insights: IDX Composite Stability and Trends
• Understanding the RomCom Cyber Exploit: Latest Insights
• MicroStrategy Faces 23% Plunge Amid Bitcoin's Market Shift
• South32 Announces Updates on Share Buy-Back Activities